Xencor


Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Industries

Employees

201-500

Links


Org chart

Bassil I. Dahiyat
President, CEO & Director
Collapse
John R. Desjarlais
EVP, Research & Chief Scientific Officer
Nancy Valente
EVP & Chief Development Officer
John J. Kuch
SVP & CFO
Celia Eckert
SVP, General Counsel & Corporate Secretary
Kirk Rosemark
SVP, Regulatory Affairs & Quality Assurance
Norman Barlow
Senior Vice President
Dane Leone
Evp, Chief Strategy Officer
Bart Cornelissen
Chief Financial Officer
Matthew Bernett
Executive Director
John Kuch
Senior Vice President And CFO
Tami See
Director, Clinical Data Management

Board & advisors